Log In
Print
BCIQ
Print
Print this Print this
 

Bridion, sugammadex (MK-8616) (formerly Org 25969, SCH 900616)

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionCyclodextrin derivative
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAnesthesia
Indication DetailsReverse neuromuscular blockade; Reverse shallow and profound neuromuscular block
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today